What is the recommended dose of epinephrine (adrenaline) for treating hypotension, including both bolus and infusion doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Hypotension

For hypotension associated with septic shock, initiate epinephrine as a continuous infusion at 0.05-2 mcg/kg/min, titrated to achieve a mean arterial pressure (MAP) of 65 mmHg or higher; for acute perioperative anaphylaxis with moderate hypotension, administer 20 mcg IV bolus, escalating to 50 mcg at 2 minutes if unresponsive, while for life-threatening hypotension or cardiac arrest, give 100 mcg or 1 mg boluses respectively. 1, 2

Continuous Infusion Dosing (Primary Method for Septic Shock)

Preparation and Initial Dosing

  • Dilute 1 mg (10 mL) of epinephrine in 1,000 mL of 5% dextrose solution to produce a 1 mcg/mL concentration 1
  • Start infusion at 0.05 mcg/kg/min and titrate up to 2 mcg/kg/min to achieve desired MAP 1
  • Adjust dosage every 10-15 minutes in increments of 0.05-0.2 mcg/kg/min until blood pressure goal is met 1
  • Target MAP ≥65 mmHg for adequate tissue perfusion 1

Administration Route and Monitoring

  • Infuse into a large vein whenever possible to minimize extravasation risk 1
  • Avoid leg veins in elderly patients or those with occlusive vascular disease 1
  • Do not use catheter tie-in technique as it may cause stasis and increased local drug concentration 1
  • Continuous hemodynamic monitoring is essential during administration 2

Weaning Protocol

  • After hemodynamic stabilization, wean incrementally over 12-24 hours by decreasing doses every 30 minutes 1

Bolus Dosing (For Perioperative Anaphylaxis)

Grade II Reactions (Moderate Hypotension/Bronchospasm)

  • Initial dose: 20 mcg IV when vasopressor or bronchodilator is clinically indicated 2
  • Escalation: 50 mcg at 2 minutes if unresponsive to initial dose 2
  • If IV access is unavailable, administer 300 mcg IM 2

Grade III Reactions (Life-Threatening Hypotension/Bronchospasm)

  • Initial dose: 50 mcg IV if no other vasopressors/bronchodilators have been given 2
  • Alternative: 100 mcg IV where unresponsive to other vasopressors/bronchodilators 2
  • Escalation: 200 mcg at 2 minutes if unresponsive to initial dose 2

Grade IV Reactions (Cardiac or Respiratory Arrest)

  • Follow advanced life support guidelines with 1 mg (1,000 mcg) IV boluses 2
  • Initiate cardiac compressions for inadequate cardiac output or systolic BP <50 mmHg 2

Refractory Hypotension Management (After 10 Minutes)

Escalation Strategies

  • Double the bolus dose if inadequate sustained response 2
  • Commence epinephrine infusion at 0.05-0.1 mcg/kg/min peripherally 2
  • Start infusion when more than three epinephrine boluses have been administered 2
  • Consider 500 mcg IM bolus while preparing infusion 2

Alternative Infusion Protocol for Anaphylaxis

  • Prepare 1:100,000 solution (1 mg in 100 mL saline) 2
  • Administer at initial rate of 30-100 mL/h (5-15 mcg/min) 2
  • Titrate based on clinical response or epinephrine side effects 2
  • Discontinue 30 minutes after resolution of all symptoms 2

Adjunctive Vasopressors for Persistent Hypotension

  • Add norepinephrine infusion (0.05-0.5 mcg/kg/min), phenylephrine, or metaraminol 2
  • Add vasopressin 1-2 IU bolus with or without infusion (2 units/h) 2
  • Add IV glucagon (1-2 mg) in patients using beta-blockers 2

Prehospital/Emergency Bolus Dosing

Push-Dose Epinephrine Protocol

  • Administer 10-20 mcg IV every 2 minutes until SBP ≥90 mmHg or MAP ≥65 mmHg 3, 4
  • Research demonstrates median MAP increase of 11 mmHg with 20 mcg doses 4
  • Effective in 58.5% of cases for resolving hypotension during transport 3
  • Minimal adverse events: single episode of transient hypertension in 100 doses administered 3

Critical Precautions and Contraindications

Fluid Resuscitation Requirements

  • Administer crystalloid 500 mL rapid bolus for Grade II reactions and repeat if inadequate response 2
  • Administer 1 L crystalloid rapid bolus for Grade III reactions and repeat if inadequate response 2
  • For septic shock, ensure minimum 30 mL/kg crystalloid bolus before or concurrent with epinephrine 2

Monitoring for Adverse Effects

  • Watch for acute severe hypertension (SBP >180 mmHg) 1
  • Monitor for potentially serious cardiac arrhythmias and myocardial ischemia, particularly in patients with underlying heart disease 1
  • Risk of pulmonary edema, which may be fatal 1
  • Potential for oliguria or renal impairment 1

Extravasation Management

  • Avoid extravasation into tissues, which causes local necrosis 1
  • If extravasation occurs, infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the site immediately 2

Drug Interactions

  • Do not mix with sodium bicarbonate or alkaline solutions in IV line, as epinephrine is inactivated 2
  • Use cautiously with beta-blockers, tricyclic antidepressants, MAO inhibitors, and COMT inhibitors, which potentiate effects 1
  • Alpha-blockers, vasodilators, and antihypertensives counter pressor effects 1

Common Pitfalls to Avoid

  • Never delay epinephrine in anaphylaxis: Grade III/IV reactions require immediate administration, not stepwise escalation from lower doses 2
  • Avoid using saline solution alone for epinephrine infusions; always use dextrose-containing solutions 1
  • Do not underdose in life-threatening situations: 100 mcg or 1 mg boluses are appropriate for severe reactions, not the 20 mcg used for moderate hypotension 2
  • Ensure adequate volume resuscitation: epinephrine without fluid replacement may worsen organ perfusion despite improved blood pressure 2
  • Monitor for rebound hypotension: wean gradually over 12-24 hours rather than abrupt discontinuation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.